Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Interpace Biosciences Inc - SIC # 8011 - OFFICES AND CLINICS OF DOCTORS OF MEDICINE
Ticker
Exchange
SIC #
Website
Latest Ticker
IDXG
Over the counter
8011
https://www.interpace.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Interpace Biosciences Inc
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
- Mar 7th, 2024 1:00 pm
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
- Nov 8th, 2023 8:29 pm
Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
- Aug 9th, 2023 4:30 pm
Interpace Biosciences Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® Reimbursement
- Jul 10th, 2023 7:59 pm
Interpace Expects to Stop Offering PancraGEN® Test Due to CMS Decision to End Reimbursement as of July 17, 2023
- Jun 5th, 2023 8:05 pm
Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results
- May 12th, 2023 8:05 pm
Scroll